Source:http://linkedlifedata.com/resource/pubmed/id/18671950
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2008-9-8
|
pubmed:abstractText |
The glycolipid alpha-galactosylceramide (alpha-GalCer), when presented on CD1 molecules by antigen presenting cells (APCs) to invariant NKT (iNKT cells), is a potent immunomodulator. Indoleamine 2,3-dioxygenase (IDO), an enzyme catalyzing the catabolism of L-tryptophan along the kynurenine pathway, is inducible in APC and represents one of the main endogenous mechanisms of T cell homeostasis, peripheral tolerance and immunosuppression. No data have been published yet on the effect of alpha-GalCer on IDO in APC. We aimed to determine if: (1) alpha-GalCer modulates IDO in APC; (2) the alpha-GalCer-induced effect on IDO correlates with the production by APC of active compounds; (3) the medium from alpha-GalCer-treated APC is able to stimulate iNKT cells. From our results alpha-GalCer alone did not modify IDO expression (RT-PCR) in APC, but when human peripheral blood mononuclear cells (PBMC), monocytes, and monocytic cell lines (THP-1), expressing high levels of CD1d, were treated with interferon-gamma (IFN-gamma) plus alpha-GalCer a significant potentiation of IDO transcription was measured. This effect was not induced by increased IFN-gamma release by APC, and it was functionally correlated with increased L-kynurenine (L-KYN) release by alpha-GalCer-treated CD1d-transfected THP-1 cells. The medium of these cells stimulated iNKT hybridoma cells to release interleukin (IL)-2, while alpha-GalCer alone resulted ineffective. The data demonstrate that alpha-GalCer: (1) does not induce IFN-gamma release by APC; (2) potentiates IFN-gamma-induced IDO expression and function in APC; (2) requires CD1d molecules for inducing these effects; (3) induces the release by APC of compounds active in stimulating iNKT cells.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adjuvants, Immunologic,
http://linkedlifedata.com/resource/pubmed/chemical/Galactosylceramides,
http://linkedlifedata.com/resource/pubmed/chemical/Indoleamine-Pyrrole 2,3,-Dioxygenase,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-gamma,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-galactosylceramide
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1873-2968
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
76
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
738-50
|
pubmed:dateRevised |
2009-5-21
|
pubmed:meshHeading |
pubmed-meshheading:18671950-Adjuvants, Immunologic,
pubmed-meshheading:18671950-Animals,
pubmed-meshheading:18671950-Antigen-Presenting Cells,
pubmed-meshheading:18671950-Cell Line, Tumor,
pubmed-meshheading:18671950-Cells, Cultured,
pubmed-meshheading:18671950-Enzyme Induction,
pubmed-meshheading:18671950-Galactosylceramides,
pubmed-meshheading:18671950-HL-60 Cells,
pubmed-meshheading:18671950-Humans,
pubmed-meshheading:18671950-Indoleamine-Pyrrole 2,3,-Dioxygenase,
pubmed-meshheading:18671950-Interferon-gamma,
pubmed-meshheading:18671950-Killer Cells, Natural,
pubmed-meshheading:18671950-Mice,
pubmed-meshheading:18671950-Mice, Inbred C57BL,
pubmed-meshheading:18671950-Monocytes,
pubmed-meshheading:18671950-T-Lymphocyte Subsets
|
pubmed:year |
2008
|
pubmed:articleTitle |
Alpha-galactosylceramide modulates the induction of indoleamine 2,3-dioxygenase in antigen presenting cells.
|
pubmed:affiliation |
DISCAFF Department, University of Piemonte Orientale, Via Bovio, 6, 28100 Novara, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|